Chagas Disease and Domestic Medical Screening Guidance for Newly Arrived Individuals Under a Humanitarian-Based Immigration Status: A Call for Action

Am J Trop Med Hyg. 2022 Nov 14;107(5):960-963. doi: 10.4269/ajtmh.22-0309. Print 2022 Nov 14.

Abstract

Chagas disease is considered one of the most important neglected tropical diseases in the Western Hemisphere, given its morbidity, mortality, and societal and economic burden. The United States has the fifth highest global burden of Chagas disease. Every year, thousands of migrant people from Latin America and throughout the globe travel to the U.S.- Mexico border searching for asylum. The U.S. CDC's Guidance for the U.S. Domestic Medical Examination for Newly Arriving Refugees provides recommendations to safeguard the health of individuals who enter the United States with a humanitarian-based immigration status as defined by the CDC's guidance under Key Considerations and Best Practices. We encourage the inclusion of Trypanosoma cruzi infection screening recommendations in this guidance as an important step toward understanding the risk and burden of Chagas disease in this vulnerable population, strengthening their access to care and contributing to the 2030 objectives of the WHO's neglected tropical diseases road map.

MeSH terms

  • Chagas Disease* / diagnosis
  • Chagas Disease* / epidemiology
  • Emigration and Immigration*
  • Humans
  • Latin America
  • Mass Screening
  • Mexico / epidemiology
  • United States / epidemiology